These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20601278)

  • 21. Cardiovascular effects of insulin sensitizers in diabetes.
    Jawa A; Fonseca V
    Curr Opin Investig Drugs; 2006 Sep; 7(9):806-14. PubMed ID: 17002258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advances in Antidiabetic Drugs Targeting Insulin Secretion.
    Ding Y; Li Y; Chen Q; Niu B
    Curr Pharm Des; 2018; 24(34):3990-3997. PubMed ID: 30417774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual acting and pan-PPAR activators as potential anti-diabetic therapies.
    Heald M; Cawthorne MA
    Handb Exp Pharmacol; 2011; (203):35-51. PubMed ID: 21484566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
    Ozawa H; Murai Y; Ozawa T
    Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vitamin E tocotrienols improve insulin sensitivity through activating peroxisome proliferator-activated receptors.
    Fang F; Kang Z; Wong C
    Mol Nutr Food Res; 2010 Mar; 54(3):345-52. PubMed ID: 19866471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes of the carbohydrate metabolism during combined surgical treatment in patients with diabetes mellitus complicated by necrotic-inflammatory foot injury].
    Fedorenko AV
    Klin Khir; 2002; (11-12):68-9. PubMed ID: 12549301
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiac metabolism, inflammation, and peroxisome proliferator-activated receptors modulated by 1,25-dihydroxyvitamin D3 in diabetic rats.
    Lee TI; Kao YH; Chen YC; Tsai WC; Chung CC; Chen YJ
    Int J Cardiol; 2014 Sep; 176(1):151-7. PubMed ID: 25062566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hypoglycemic activity of hypolipidemic preparations].
    Titov VN
    Klin Med (Mosk); 2014; 92(5):18-28. PubMed ID: 25782302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peroxisome proliferator-activated receptors modulate cardiac dysfunction in diabetic cardiomyopathy.
    Lee TI; Kao YH; Chen YC; Huang JH; Hsiao FC; Chen YJ
    Diabetes Res Clin Pract; 2013 Jun; 100(3):330-9. PubMed ID: 23369225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chemically chaperoning the actions of insulin.
    Hansen PA; Waheed A; Corbett JA
    Trends Endocrinol Metab; 2007; 18(1):1-3. PubMed ID: 17116401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the unfolded protein response for disease intervention.
    Rivas A; Vidal RL; Hetz C
    Expert Opin Ther Targets; 2015; 19(9):1203-18. PubMed ID: 26166159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting endoplasmic reticulum stress in metabolic disease.
    Cao SS; Kaufman RJ
    Expert Opin Ther Targets; 2013 Apr; 17(4):437-48. PubMed ID: 23324104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoplasmic reticulum stress, obesity and diabetes.
    Cnop M; Foufelle F; Velloso LA
    Trends Mol Med; 2012 Jan; 18(1):59-68. PubMed ID: 21889406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Healing the diabetic heart: modulation of cardiometabolic syndrome through peroxisome proliferator activated receptors (PPARs).
    Huang TH; Roufogalis BD
    Curr Mol Pharmacol; 2012 Jun; 5(2):241-7. PubMed ID: 22122453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
    Ahmed W; Ziouzenkova O; Brown J; Devchand P; Francis S; Kadakia M; Kanda T; Orasanu G; Sharlach M; Zandbergen F; Plutzky J
    J Intern Med; 2007 Aug; 262(2):184-98. PubMed ID: 17645586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome-proliferator-activated receptors.
    Yumuk VD
    Ann N Y Acad Sci; 2006 Nov; 1083():306-18. PubMed ID: 17148746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promising new approaches.
    Reasner CA
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antidiabetic efficacy of citronellol, a citrus monoterpene by ameliorating the hepatic key enzymes of carbohydrate metabolism in streptozotocin-induced diabetic rats.
    Srinivasan S; Muruganathan U
    Chem Biol Interact; 2016 Apr; 250():38-46. PubMed ID: 26944432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overview of key molecular and pharmacological targets for diabetes and associated diseases.
    Shahcheraghi SH; Aljabali AAA; Al Zoubi MS; Mishra V; Charbe NB; Haggag YA; Shrivastava G; Almutary AG; Alnuqaydan AM; Barh D; Dua K; Chellappan DK; Gupta G; Lotfi M; Serrano-Aroca Á; Bahar B; Mishra YK; Takayama K; Panda PK; Bakshi HA; Tambuwala MM
    Life Sci; 2021 Aug; 278():119632. PubMed ID: 34019900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced expression of ERp46 under diabetic conditions in β-cells and the effect of liraglutide.
    Lampropoulou E; Lymperopoulou A; Charonis A
    Metabolism; 2016 Jan; 65(1):7-15. PubMed ID: 26683792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.